205
Participants
Start Date
July 15, 2018
Primary Completion Date
January 9, 2025
Study Completion Date
January 9, 2025
Setmelanotide
Once daily subcutaneous injection
Charité - Universitätsmedizin Berlin, Berlin
University at Buffalo, Buffalo
Childrens Hospital of Philadephia, Philadelphia
University General Hospital of Patras, Rio
Wake Research, Raleigh
Duke University Medical Center, Durham
Synexus Clinical Research US, Inc.- Primary Care Associates, PC, Anderson
University of Florida College of Medicine, Gainesville
Vanderbilt University Medical Center, Nashville
Wake Research TN, Chattanooga
Marshfield Clinic Research Institute, Marshfield
Hôpital Trousseau, Paris
Hôpital de la Pitié Salpêtrière, Paris
Synexus Clinical Research US, Inc. - Phoenix Southeast, Chandler
Honor Health Research Institute, Scottsdale
University of Ulm, Ulm
San Diego Wake Research, San Diego
Seattle Children's Research Institute, Seattle
Baystate Medical Center, Springfield
Obesity Institute, Geisinger Clinic, Danville
University of Alberta, Edmonton
University of Leipzig, Leipzig
Erasmus MC, Rotterdam
Universidad Autónoma de Madrid, Madrid
University Hospitals Birmingham NHS Foundation Trust, Birmingham
Wellcome Trust-MRC Institute of Metabolic Science, Cambridge
Hammersmith Hospital, London
Rhythm Pharmaceuticals, Inc.
INDUSTRY